What's in Idorsia Pharmaceuticals Ltd.'s pipeline?

Idorsia Pharmaceuticals Ltd. has 18 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 3 in Phase 2, 14 in Phase 1.

Which companies overlap with Idorsia Pharmaceuticals Ltd.'s portfolio?

Top competitors by shared drug class: Apnimed, Assistance Publique - Hôpitaux de Paris, Intec Pharma Ltd., Massachusetts General Hospital, Merck Sharp & Dohme LLC.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/idorsia-pharmaceuticals-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Idorsia Pharmaceuticals Ltd. — Portfolio Competitive Intelligence Brief

Idorsia Pharmaceuticals Ltd. pipeline: 0 marketed, 0 filed, 1 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 3 Phase 2 14 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
ACT-129968	ACT-129968	phase 3	Orexin 2 receptor antagonist	OX2R (Orexin 2 receptor)	Neurology / Sleep Medicine

Therapeutic area mix

Psychiatry · 2
Neurology / Sleep Medicine · 1
Sleep disorders · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Apnimed · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Intec Pharma Ltd. · 1 shared drug class
Massachusetts General Hospital · 1 shared drug class
Merck Sharp & Dohme LLC · 1 shared drug class
Otsuka Pharmaceutical Co., Ltd. · 1 shared drug class
Shanghai Mental Health Center · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Idorsia Pharmaceuticals Ltd.:

Cite this brief

Drug Landscape (2026). Idorsia Pharmaceuticals Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/idorsia-pharmaceuticals-ltd. Accessed 2026-05-16.